Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

64.31
+0.26500.41%
Volume:4.10M
Turnover:255.59M
Market Cap:11.60B
PE:-44.85
High:64.55
Open:62.25
Low:60.58
Close:64.04
52wk High:104.32
52wk Low:40.77
Shares:180.43M
Float Shares:115.00M
Volume Ratio:0.93
T/O Rate:3.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:26.08
PE(LYR):-45.61

Loading ...

Tempus to Acquire Personalis for $1.5 Billion

Reuters
·
Jul 20

Tempus AI to acquire Personalis for $16.25 per share

TIPRANKS
·
Jul 20

Tempus AI Agrees to Buy Personalis for USD 16.25 Per Share in USD 1.5 Billion Deal

Reuters
·
Jul 20

Tempus AI Inc - Maximum Exchange Ratio Set at 0.3356 Tempus AI Shares Per Personalis Share

THOMSON REUTERS
·
Jul 20

Tempus - Consideration Structured as 100% Stock, Cash Option Capped at 50%

THOMSON REUTERS
·
Jul 20

Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (mrd) into Its Ai-enabled Precision Oncology Platform

THOMSON REUTERS
·
Jul 20

Tempus AI Inc - Cash Consideration Will be Financed with Cash on Hand and Borrowings Under Company's Then Existing Credit Facilities

THOMSON REUTERS
·
Jul 20

Dimon Warns AI Risks

AI Industry Frontlines
·
Jul 17

How Do Tempus AI’s (TEM) NHS Prostate Results Shape Its Clinical Credibility Narrative?

Simply Wall St.
·
Jul 17

AI Trading Has Become a 'Rubber Band,' Goldman Sachs Top Trader: The Question is 'When Will It Snap'

AI Industry Frontlines
·
Jul 17

AI Market Outlook; The Era Of Risk-Free Gains Has Come To An End

AI Industry Frontlines
·
Jul 17

Movement Alert|Tempus AI Falls 5.17% in Regular Trading, Partnership Termination and Executive Share Reduction Continue to Weigh on Stock

Market Focus
·
Jul 17

Tempus Cites Real-world UK NHS Study Showing Prostate Pathology AI Changes Diagnosis in 5% of Cases

Reuters
·
Jul 16

Tempus AI is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 16

Tempus AI price target raised to $71 from $68 at TD Cowen

TIPRANKS
·
Jul 15

Movement Alert|Tempus AI Rises 5.19% in Regular Trading, Trading at $58.755

Market Focus
·
Jul 15

Movement Alert|Tempus AI Falls 5.05% in Regular Trading, Collaboration Termination and Insider Selling Continue to Weigh on Shares

Market Focus
·
Jul 14

Anthropic Delays Claude Fable 5 Billing; OpenAI Removes GPT-5.6 Sol Usage Caps

AI Industry Frontlines
·
Jul 13

Tempus AI CEO, Data Ryan Fukushima Reports Disposal of $1.91 Million in Common Shares

Reuters
·
Jul 11

Movement Alert|Tempus AI Falls 5.01% in Regular Trading, Partnership Termination and Executive Share Sales Continue to Weigh on Sentiment

Market Focus
·
Jul 10